Skip to content
10-Q

Quarterly Report

SCOPUS BIOPHARMA INC.

0001410578-23-001110

← back to feed
Filed
May 12, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 8, 2023 39.78M sh
Shares Diluted Q1 2023 · Mar 31, 2023 30.37M sh
Shares Diluted Q1 2023 · Mar 31, 2022 21.09M sh
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$759.86K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$3.98M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $1.4M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $124.58K
Stockholders Equity Q1 2023 · Mar 31, 2023 −$6.95M
Stockholders Equity Q1 2023 · Dec 31, 2022 −$6.56M
Current Liabilities Q1 2023 · Mar 31, 2023 $9.31M
Current Liabilities Q1 2023 · Dec 31, 2022 $7.45M
Current Assets Q1 2023 · Mar 31, 2023 $1.6M
Current Assets Q1 2023 · Dec 31, 2022 $390K
Total Assets Q1 2023 · Mar 31, 2023 $1.6M
Total Assets Q1 2023 · Dec 31, 2022 $392.27K
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.08
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.22
Eps Basic Q1 2023 · Mar 31, 2023 −$0.08
Eps Basic Q1 2023 · Mar 31, 2022 −$0.22
Sga Expense Q1 2023 · Mar 31, 2023 $1.07M
Sga Expense Q1 2023 · Mar 31, 2022 $4.29M
Rd Expense Q1 2023 · Mar 31, 2023 $1.61M
Rd Expense Q1 2023 · Mar 31, 2022 $369.11K
Net Income Q1 2023 · Mar 31, 2023 −$2.45M
Net Income Q1 2023 · Mar 31, 2022 −$4.66M
Revenue Q1 2023 · Mar 31, 2023 $0
Revenue Q1 2023 · Mar 31, 2022 $0
Capex Q1 2023 · Mar 31, 2022 $1.55K